©The Author(s) 2025.
World J Gastroenterol. Oct 21, 2025; 31(39): 110986
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.110986
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.110986
Figure 5 Mechanisms of action of repurposed drugs with other target proteins/pathways.
Purple form indicated main pathway proteins; light blue form indicated drugs; dark blue form indicated proteins involved in the mechanism of action of the drug; “?” symbol indicated target is not clear. ERK: Extracellular signal-regulated kinase; HIF-1α: Hypoxia-inducible factor-1α; NF-κB: Nuclear factor kappa B; TERT: Telomerase reverse transcriptase; TGF-β1: Transforming growth factor-β1; EGFR: Epidermal growth factor receptor; DR: Dopamine receptor.
- Citation: Valero-Almingol A, Montori S, Felípez N, Santamaría E, Fernandez-Irigoyen J, Luzko I, Cuestas AA, Pardo C, Prat R, Moreira L, Albéniz E. Targetable pathways for drug repurposing in gastric cancer. World J Gastroenterol 2025; 31(39): 110986
- URL: https://www.wjgnet.com/1007-9327/full/v31/i39/110986.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i39.110986